Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jun-Jul;25(6):910-8.

White matter lesions in panencephalopathic type of Creutzfeldt-Jakob disease: MR imaging and pathologic correlations

Affiliations

White matter lesions in panencephalopathic type of Creutzfeldt-Jakob disease: MR imaging and pathologic correlations

Eiji Matsusue et al. AJNR Am J Neuroradiol. 2004 Jun-Jul.

Abstract

Background and purpose: A panencephalopathic type of Creutzfeldt-Jakob disease (pCJD) is characterized by the extensive involvement of the cerebral white matter as well as the cerebral gray matter. It has been a point of controversy, however, whether the white matter changes represent primary or secondary degeneration. The aim of this study was to elucidate, by using MR images and histologic examinations, whether the white matter lesions in pCJD are primary or secondary degeneration.

Methods: Serial changes of T2 hyperintensities and histologic findings of six autopsy-proved cases of pCJD were retrospectively analyzed.

Results: Serial MR images of brains affected by pCJD revealed that T2 hyperintensities appeared in the cerebral gray matter 2-5 months after onset and in the cerebral white matter around the lateral ventricles approximately 5 months after onset. They rapidly extended to deep and subcortical white matter during the next several months and then to the entire cerebral white matter 10 months after onset. Histologic examination of the white matter lesions revealed spongy changes or tissue rarefaction associated with gemistocytic astrocytosis, which indicates primary involvement of the white matter. At the terminal stages of cases with a longer clinical course, MR images showed T2 hyperintensities in the corticospinal tracts in the internal capsule and brain stem, which histologically disclosed loss of myelin and axons accompanied by fibrillary gliosis that indicates secondary degeneration.

Conclusion: Cerebral white matter lesions in pCJD were considered to be primary changes of the disease, but the lesions of the corticospinal tracts were secondary to cortical or cerebral or both white matter lesions.

PubMed Disclaimer

Figures

F<sc>ig</sc> 1.
Fig 1.
Serial axial T2-weighted (A and B) and FLAIR (C and D) images in case 1 obtained 2 (A and C) and 4 (B and D) months after onset of symptoms. FLAIR and T2-weighted images show faint hyperintensity in the left putamen. The finding is more conspicuous on the FLAIR image (C, arrow) than on the T2- weighted image (A, arrow). FLAIR image shows hyperintensities not only in the bilateral striatum (D, arrows) and cerebral cortices, but also in the periventricular white matter (D, arrowheads) with mild cerebral atrophy 4 months after onset. T2-weighted images also show hyperintensities in both the striatum (B, arrows) and periventricular white matter (B, arrowheads), although not as conspicuously as on FLAIR images 4 months after onset. Signal intensity in the cerebral cortex is susceptible to the partial volume artifact with the surrounding CSF on T2-weighted images (A and B).
F<sc>ig</sc> 2.
Fig 2.
Serial axial T2-weighted MR images from case 4 obtained (A) 3 months, (B) 5 months, (C) 7 months, (D) 9 months, (E) 12 months, and (F) 18 months after onset of symptoms. Slight hyperintensities are shown around the lateral ventricles (B, arrows) 5 months after the onset. The periventricular hyperintensities are gradually extending to the deep and subcortical white matter in parallel with cortical atrophy (CF).
F<sc>ig</sc> 3.
Fig 3.
Serial axial T2-weighted MR images in case 6 obtained at 11 months (A, D, and G), 18 months (B, E, and H), and 28 months (C, F, and I) after the onset of symptoms. The degree of brain atrophy gradually becomes apparent. Only in this case, T2 hyperintensities are never seen in the basal ganglia at any stage. At 11 months after onset, diffuse T2 hyperintensities in the cerebral white matter are evident, but hyperintensities are not visible in the internal capsules (A). At 18 months, T2 hyperintensities are observed in both internal capsules (B, arrows). At 28 months, high signal intensity of the bilateral internal capsules is apparent (C, arrows). T2 hyperintensities are also visible in both cerebral peduncles (F, arrows), pons (I, arrows), and middle cerebellar peduncles (I, arrowheads).
F<sc>ig</sc> 4.
Fig 4.
A, Postmortem coronal T2-weighted image of the right frontal lobe 22 months after the onset in case 3, showing diffuse hyperintensities in the cerebral white matter. B, Myelin-stained section corresponding to panel A, demonstrating diffuse pallor of the cerebral white matter. C, Histologic specimen of the area of highly increased signal intensity (A and B, squares), revealing a severe loss of myelin and axons, tissue rarefaction, foamy macrophages (arrowhead), and proliferation of gemistocytic astrocytes (arrow). D, Area of moderately increased signal intensity (A and B, circles), showing mild tissue rarefaction. There are also foamy macrophages (arrowhead) and gemistocytic astrocytes (arrow). Because tissue rarefaction and gemistocytic astrocytosis are exceptional features in secondary degeneration, these histologic features indicate primary involvement of the white matter.
F<sc>ig</sc> 5.
Fig 5.
A, Postmortem coronal T2-weighted image of the right frontal lobe 8 months after the onset of symptoms in case 1, showing hyperintensities around the anterior horn of the lateral ventricle and adjacent deep cerebral white matter. B, Myelin-stained section corresponding to panel A, showing pallor of the cerebral white matter, which is more widespread than the extent of hyperintensities on the MR image. C, Histologic specimen of the area of moderately increased signal intensity (A and B, squares), revealing mild loss of myelin and axons with a few hypertrophic astrocytes (arrows). D, Area of normal signal intensity (A and B, circles), showing no apparent degenerative changes.
F<sc>ig</sc> 6.
Fig 6.
A and B, Postmortem axial T2-weighted images of the midbrain (A) and pons (B) 28 months after the onset of symptoms in case 5, showing hyperintensities in the cerebral peduncles (A, arrows), pons (B, arrows), and middle cerebellar peduncles (B, arrowheads) involving the longitudinal fasciculi, pontine nuclei, and pontine transverse fibers. C and D, The myelin-stained sections corresponding to panels A and B demonstrate severe pallor of the cerebral peduncles (C), pons, and middle cerebellar peduncles (D). E, Histologically, the cerebral peduncle shows severe loss of myelin and axons with moderate macrophage infiltration (arrowheads) and fibrillary gliosis, characteristics compatible with secondary degeneration. F, Pontine nuclei reveal neuronal loss and proliferation of hypertrophic astrocytes (arrows). G, Middle cerebellar peduncle shows severe loss of myelin and axons with moderate macrophage infiltration (arrowheads) but no gemistocytic astrocytes, a characteristic compatible with secondary degeneration.

Comment in

Similar articles

Cited by

References

    1. Gonatas NK, Terry RD, Weiss M. Electron microscopic study in two cases of Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 1965;24:575–598 - PubMed
    1. Lampert PW, Gajdusek DC, Gibbs CJ. Subacute spongiform virus encephalopathies. Am J Pathol 1972;68:626–646 - PMC - PubMed
    1. Park TS, Kleinman GM, Richardson EP. Creutzfeldt-Jakob disease with extensive degeneration of white matter. Acta Neuropathol 1980;52:239–242 - PubMed
    1. Monreal J, Collins GH, Masters CL, et al. Creutzfeldt-Jakob disease in an adolescent. J Neurol Sci 1981;52:341–350 - PubMed
    1. Macchi G, Abbamondi AL, Di Trapani G, et al. On white matter lesions of the Creutzfeldt-Jakob disease. J Neurol Sci 1984;63:197–206 - PubMed